Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferrante

Showing results (231-240 of 233) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 233 results.
Neurourology and Urodynamics|April 18, 2024
A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.
The Journal of Urology|November 25, 2024
Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary IncontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.
Neurology|December 14, 2005
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALSK L Ferrante, J Shefner, H Zhang, et al.
Pageof 24

Showing results (231-240 of 233) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 233 results.
Neurourology and Urodynamics|April 18, 2024
A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.
The Journal of Urology|November 25, 2024
Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary IncontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.
Neurology|December 14, 2005
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALSK L Ferrante, J Shefner, H Zhang, et al.
Pageof 24